These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
Pubmed for Handhelds
PUBMED FOR HANDHELDS
Journal Abstract Search
328 related items for PubMed ID: 21413974
1. Botulinum toxin type B for sialorrhoea in children with cerebral palsy: a randomized trial comparing three doses. Basciani M, Di Rienzo F, Fontana A, Copetti M, Pellegrini F, Intiso D. Dev Med Child Neurol; 2011 Jun; 53(6):559-64. PubMed ID: 21413974 [Abstract] [Full Text] [Related]
2. Parotid and submandibular botulinum toxin A injections for sialorrhoea in children with cerebral palsy. Banerjee KJ, Glasson C, O'Flaherty SJ. Dev Med Child Neurol; 2006 Nov; 48(11):883-7. PubMed ID: 17044954 [Abstract] [Full Text] [Related]
5. Drooling in children with cerebral palsy: effect of salivary flow reduction on daily life and care. Van der Burg JJ, Jongerius PH, Van Hulst K, Van Limbeek J, Rotteveel JJ. Dev Med Child Neurol; 2006 Feb; 48(2):103-7. PubMed ID: 16417664 [Abstract] [Full Text] [Related]
6. Successful treatment of drooling in children with neurological disorders with botulinum toxin A or B. Wilken B, Aslami B, Backes H. Neuropediatrics; 2008 Aug; 39(4):200-4. PubMed ID: 19165707 [Abstract] [Full Text] [Related]
7. Randomized trial of botulinum toxin injections into the salivary glands to reduce drooling in children with neurological disorders. Reid SM, Johnstone BR, Westbury C, Rawicki B, Reddihough DS. Dev Med Child Neurol; 2008 Feb; 50(2):123-8. PubMed ID: 18201301 [Abstract] [Full Text] [Related]
8. Safety and efficacy of botulinum toxin type B for treatment of sialorrhea in Parkinson's disease: a prospective double-blind trial. Chinnapongse R, Gullo K, Nemeth P, Zhang Y, Griggs L. Mov Disord; 2012 Feb; 27(2):219-26. PubMed ID: 21887710 [Abstract] [Full Text] [Related]
9. Salivary gland botulinum toxin injections for drooling in children with cerebral palsy and neurodevelopmental disability: a systematic review. Rodwell K, Edwards P, Ware RS, Boyd R. Dev Med Child Neurol; 2012 Nov; 54(11):977-87. PubMed ID: 22946706 [Abstract] [Full Text] [Related]
11. What could predict effectiveness of Botulinum Toxin to treat drooling: a search for evidence of discriminatory factors on the level of body functions or structures. Erasmus CE, van Hulst K, Scheffer AR, van Limbeek J, van den Hoogen FJ, Rotteveel JJ, Jongerius PH. Eur J Paediatr Neurol; 2012 Mar; 16(2):126-31. PubMed ID: 21783393 [Abstract] [Full Text] [Related]
12. Botulinum toxin effect on salivary flow rate in children with cerebral palsy. Jongerius PH, Rotteveel JJ, van Limbeek J, Gabreëls FJ, van Hulst K, van den Hoogen FJ. Neurology; 2004 Oct 26; 63(8):1371-5. PubMed ID: 15505151 [Abstract] [Full Text] [Related]
14. Botulinum toxin injections for chronic sialorrhoea in children are effective regardless of the degree of neurological dysfunction: A single tertiary institution experience. Mahadevan M, Gruber M, Bilish D, Edwards K, Davies-Payne D, van der Meer G. Int J Pediatr Otorhinolaryngol; 2016 Sep 26; 88():142-5. PubMed ID: 27497402 [Abstract] [Full Text] [Related]
18. Relevance of intraglandular injections of Botulinum toxin for the treatment of sialorrhea in children with cerebral palsy: a review. Porte M, Chaléat-Valayer E, Patte K, D'Anjou MC, Boulay C, Laffont I. Eur J Paediatr Neurol; 2014 Nov 26; 18(6):649-57. PubMed ID: 24931915 [Abstract] [Full Text] [Related]